Life Sciences companies continue to respond to a changing global landscape, and strive to pursue innovative solutions to address today's most pressing challenges. The Life Sciences and Health Care industry group understands the complexity of these challenges, and works with clients worldwide to drive progress and bring discoveries to life. As technology, government, and research shape the evolution of the life sciences industry, Deloitte's global network can help clients address today's challenges and prepare for the future. To learn more about Deloitte's global industry practice and the services offered to clients, contact the LSHC group.
|Transformation beyond reform: A changing life sciences & health care industry
In conjunction with the Financial Times/Deloitte 2013 Health Care & Life Sciences conference, explore what lies ahead for global life sciences companies as they focus on the practicalities of dealing with the provisions and impacts of U.S. health care reform.
|Health care reform and life sciences: Threat, opportunity or both?
New survey shows enhancing innovation, reducing costs, widening market access, and changing sales models are seen as major impacts on the life sciences industry from health care reforms around the world.
|Opportunities and change in the pharmaceutical industry
Deloitte Mexico event explores the latest developments and importance of the pharma sector in Mexico, and the challenges and opportunities in the areas of regulatory and compliance.
|2013 Global life sciences sector outlook
New report examines the current state of the global life sciences industry, explores top issues, reviews activity in a number of geographic markets, and suggests considerations for companies as they seek to grow revenue and market share in 2013 and beyond.